Drug maker Abbott India Ltd has reported a 24 percent year-on-year (YoY) growth in net profit at Rs 287 crore for the fourth quarter of the financial year 2023-24.
The company's revenue increased 7 percent to Rs 1,439 crore from Rs 1,343 crore in the year-ago period, Abbott India said on May 9.
The company's board recommended payment of final dividend of Rs 410 per equity share of Rs 10 each for the year ended March 31, 2024, subject to approval of the shareholders.
Shares of Abbott India closed 1.31 percent lower at Rs 25,606.55 apiece on BSE.
Abbott India, a subsidiary of Abbott Laboratories, has positioned itself as a market leader in pharmaceuticals, nutrition, devices and diagnostics. It offers over 400 brands, nutritional products for infants, children, adults and people with special dietary needs along with medical devices and diagnostics solutions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
